Literature DB >> 21510811

Interferon-γ and nitric oxide production during Behçet uveitis: immunomodulatory effect of interleukin-10.

Houda Belguendouz1, Djamel Messaoudène, Karima Lahmar, Laid Ahmedi, Osama Medjeber, Dahbia Hartani, Ouidad Lahlou-Boukoffa, Chafia Touil-Boukoffa.   

Abstract

Uveitis is one of the major manifestations of Behçet Disease, a systemic inflammatory vasculitis. Our aim is to investigate in vivo and in vitro production of interferon (IFN)-γ and nitric oxide (NO) during Behçet uveitis (BU). Moreover, we evaluated the implication of IFN-γ and interleukin (IL)-10 in the regulation of NO production in vitro. Cytokines' concentrations were measured by ELISA, and NO levels were assessed by modified Griess's method. Our results showed that patients with active disease had significant elevation of IFN-γ and NO concentrations in both plasma and peripheral blood mononuclear cell culture supernatants compared with controls (P<0.01) or to patients with inactive disease (P<0.05). Further, IFN-γ induced significantly higher production of NO in cell culture supernatants, whereas IL-10 significantly reduced it (P<0.05). In conclusion, the elevated levels of IFN-γ in vivo and in vitro in patients with BU reflect the implication of this cytokine in the disease physiopathology. These results suggest that IFN-γ, through the induction of NO synthase 2 and the production of NO, is implicated in the genesis of the inflammatory process during active BU; whereas IL-10 seems to have protective properties.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21510811     DOI: 10.1089/jir.2010.0148

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  13 in total

Review 1.  Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Authors:  Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Bruno Frediani; Rossella Franceschini; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Claudia Fabiani; Luca Cantarini
Journal:  Rheumatol Int       Date:  2017-07-27       Impact factor: 2.631

2.  Ex vivo immunomodulatory effect of ethanolic extract of propolis during Celiac Disease: involvement of nitric oxide pathway.

Authors:  Oussama Medjeber; Kahina Touri; Hayet Rafa; Zineb Djeraba; Mourad Belkhelfa; Amira Fatima Boutaleb; Amina Arroul-Lammali; Houda Belguendouz; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-07       Impact factor: 4.473

3.  Attenuation of nociceptive pain and inflammatory disorders by total steroid and terpenoid fraction of Euphorbia tirucalli Linn root in experimental in vitro and in vivo model.

Authors:  Partha Palit; Dhrubojyoti Mukherjee; Poulami Mahanta; Md Shadab; Nahid Ali; Shubhadeep Roychoudhury; Md Asad; Subhash C Mandal
Journal:  Inflammopharmacology       Date:  2017-10-23       Impact factor: 4.473

4.  A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.

Authors:  Sarah Benchabane; Abdelhalim Boudjelida; Ryma Toumi; Houda Belguendouz; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  Int J Immunopathol Pharmacol       Date:  2016-05-19       Impact factor: 3.219

5.  Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.

Authors:  Fatmazohra Djaballah-Ider; Zineb Djeraba; Mourad Chemli; Nadjiba Dammene-Debbihe; Doulkifly Lounis; Houda Belguendouz; Yanis Medour; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-29       Impact factor: 4.473

6.  Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.

Authors:  Sarah Benchabane; Mourad Belkhelfa; Houda Belguendouz; Sourour Zidi; Abdelhalim Boudjelida; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-06-04       Impact factor: 4.473

7.  Ex vivo effects of flavonoïds extracted from Artemisia herba alba on cytokines and nitric oxide production in Algerian patients with Adamantiades-Behçet's disease.

Authors:  Djamel Messaoudene; Houda Belguendouz; Mohamed Laid Ahmedi; Tarek Benabdekader; Fifi Otmani; Malika Terahi; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  J Inflamm (Lond)       Date:  2011-11-21       Impact factor: 4.981

8.  Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment.

Authors:  M B Owlia; G Mehrpoor
Journal:  ISRN Pharmacol       Date:  2012-03-08

9.  Association Analysis of IL10, TNF-α, and IL23R-IL12RB2 SNPs with Behçet's Disease Risk in Western Algeria.

Authors:  Ouahiba Khaib Dit Naib; Mourad Aribi; Aicha Idder; Amel Chiali; Hakim Sairi; Isabelle Touitou; Gérard Lefranc; Mouna Barat-Houari
Journal:  Front Immunol       Date:  2013-10-21       Impact factor: 7.561

Review 10.  Immunopathogenesis of ocular Behçet's disease.

Authors:  Un Chul Park; Tae Wan Kim; Hyeong Gon Yu
Journal:  J Immunol Res       Date:  2014-07-02       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.